Condition: Liver Cirrhosis · Decompensated Cirrhosis of Liver · Sponsor: European Foundation for Study of Chronic Liver Failure
The study aims to test the effectiveness of new biomarkers (measurable molecules in our body) in predicting the health outcome of patients with liver cirrhosis discharged from the hospital after a serious complication of the disease
This description comes directly from the study's public registry record.
Anna Bosch · +34 93 227 14 03 · anna.bosch@efclif.com
Cristina Sánchez-Garrido · cristina.sanchez@efclif.com
Always discuss trial participation with your own doctor first.
| Hospital Beaujon | Clichy, France, France | Recruiting |
| University Hospital, Aachen | Aachen, Germany, Germany | Recruiting |
| Universitätsklinikum Münster | Münster, Germany, Germany | Recruiting |
| IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di S.Orsola | Bologna, Italia, Italy | Recruiting |
| A.O.U. Città della Salute e della Scienza di Torino | Torino, Italy, Italy | Recruiting |
| Hospital Universitari Vall d'Hebron Research Institute | Barcelona, Spain, Spain | Recruiting |
| Hospital Clinic de Barcelona | Barcelona, Spain, Spain | Recruiting |
| Hospital Universitario Ramon y Cajal | Madrid, Spain, Spain | Recruiting |
| Royal Free Hospital | London, United Kingdom, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06855056